Inside Health Policy July 22, 2013 PhRMA Criticizes Senate Drug Compounding Bill As Others Also Take Sides
The Pharmaceutical Research and Manufacturers of America this week spoke out against a Senate proposal to create a third regulatory category that encompasses non-traditional drug compounding.
No comments:
Post a Comment